HCPCS Level IIdrugActive
J1303
Inj., ravulizumab-cwvz 10 mg
BETOS: O1E
Effective: 2019-10-01
Description
Injection, ravulizumab-cwvz, 10 mg
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Ultomiris
Manufacturer
Alexion Pharmaceuticals, Inc.
HCPCS Dosage
10 MG
Billing Units
30.0000
2
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.